Pascal Touchon - 12 Aug 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Signature
/s/ John Chao, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 18:00:00 UTC
Previous filing
20 May 2024
Next filing
20 Aug 2024

Quoteable Key Fact

"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 14 Aug 2024."

Quick Takeaways

  • This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Filing timestamp: 14 Aug 2024, 18:00.

What Changed

  • Previous filing in this sequence was filed on 20 May 2024.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRA Employee Stock Option (Right to Buy) Disposed to Issuer $0 -9,000 -100% $0.000000* 0 12 Aug 2024 Common Stock 9,000 $510.75 Direct F1, F4
transaction ATRA Employee Stock Option (Right to Buy) Disposed to Issuer $0 -9,680 -100% $0.000000* 0 12 Aug 2024 Common Stock 9,680 $303.75 Direct F2, F4
transaction ATRA Employee Stock Option (Right to Buy) Disposed to Issuer $0 -7,075 -100% $0.000000* 0 12 Aug 2024 Common Stock 7,075 $427.63 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on June 24, 2020, and the remaining shares vested in equal monthly installments over the following 36 months.
F2 1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
F3 1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2021, subject to the reporting person's continuous service.
F4 This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .